Overall volumes in futures & options currently stand at 1.42 crore contracts with a turnover of Rs. 13,58,258.11 crore.

The company has also received a rescue offer from two prominent business families of India, the Munjals and Burmans.

Going ahead, immediate resistance is seen in the zone of 10,480-10,500. On the downside, support is seen around 10,410, followed by 10,350. Stocks in the news: NBCC, Infosys, Dabur, HCL Technologies, Texmaco Rail and Engineering and Mahindra and Mahindra.

Today, the markets are likely to make a positive opening after the US markets gained in overnight trade. Traders will now look forward to the IT major Infosys, which will declare its March quarter results today. 

Orissa Minerals Development Company shot up by 19 per cent in Thursday’s intraday trade as the company received six iron and manganese ore mines on lease from the state government of Odisha.

Mahindra Defence Systems and Bharat Electronics Limited (BEL) joined hands to harness the emerging opportunities in the Indian Defence sector. The two companies signed a MoU at the ongoing Defence Expo 2018 in Chennai.

Biocon and its partner Mylan ink an in-licensing agreement with Fujifilm Kyowa Kirin Biologics (FKB) to expedite commercialization of Adalimumab biosimilar.

Automobile giant Tata Motors announced its global wholesale figures for March 2018 on Wednesday, sending its share price up by over 2 per cent in early trade on Thursday. 

Following stocks are close to their 52-week low as at 1.09 p.m. on April 12, 2018.

Strides Shasun’s wholly-owned subsidiary Strides Pharma Global Pte. Ltd. has received approval for Cyproheptadine Hydrochloride Tablets from the United States Food & Drug Administration (USFDA), keeping its ANDA approval momentum intact.